Decintas 30 mg Injection
36,04$
32,87$
Decintas 30 mg injection is a targeted anti-cancer therapy specifically designed to address myelodysplastic syndromes (MDS), a group of disorders characterized by the ineffective production of healthy blood cells in the bone marrow. In these conditions, the bone marrow produces an excess of immature cells known as blasts, which can lead to severe health complications. By promoting the differentiation and maturation of these cells, Decintas helps restore the balance of healthy blood cell production. It is crucial for patients to be monitored regularly for potential side effects, including low blood counts and allergic reactions, which may require immediate medical attention. Prior to starting treatment, it's essential to discuss any existing health conditions or allergies with a healthcare provider to ensure safety and efficacy. This injection is typically administered under the supervision of a qualified healthcare professional to optimize its benefits. With its focused action, Decintas represents a significant advancement in the management of myelodysplastic syndromes, offering hope to those affected by these challenging disorders. Always consult your physician for personalized advice and to understand the full scope of treatment options available.
Quantité
Active Pharmaceutical Ingredient
Uses
• Decintas 30 mg injection is primarily used in the management of myelodysplastic syndrome (MDS). This condition involves the production of abnormal blood cells in the bone marrow, leading to a deficiency of healthy cells. Patients with MDS may experience symptoms such as fatigue and easy bruising. The administration of Decintas 30 mg injection aims to improve blood cell production and enhance overall patient well-being.
• Another significant application of Decintas 30 mg injection is in the treatment of acute myeloid leukemia (AML). This type of blood cancer affects the myeloid cells responsible for producing various blood components. Patients diagnosed with AML may present with symptoms like frequent infections and swollen lymph nodes. Decintas 30 mg injection helps to target and manage the abnormal cell growth associated with this disease.
• Decintas 30 mg injection is also beneficial for patients undergoing chemotherapy who may be at risk of developing complications from blood disorders. By supporting healthy blood cell production, Decintas 30 mg injection can help mitigate some of the adverse effects of cancer treatment. This supportive care is crucial for maintaining patients' quality of life during their cancer journey. The use of Decintas 30 mg injection allows healthcare providers to offer a more comprehensive treatment approach.
• In specific cases, Decintas 30 mg injection is utilized for patients who require ongoing management of their hematological conditions. It is particularly effective for those with chronic blood-related issues that necessitate a specialized treatment plan. By incorporating Decintas 30 mg injection into their therapy, patients may experience improved outcomes and enhanced management of their symptoms. This targeted approach underscores the importance of personalized treatment in oncology care.
Benefits
Myelodysplastic syndrome: Decintas 30 mg Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function and does not produce enough healthy blood cells. Decintas 30 mg Vial kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid leukemia (AML): Decintas 30 mg is used to treat acute myeloid leukemia, a type of blood cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. In AML, the myeloid cells become abnormal and do not function properly, leading to a decrease in healthy blood cells and an increase in abnormal cells. Anti-cancer Drug Decintas kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Insomnia
• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Stomach pain
• Painful sores in mouth or tongue or lips
• Indigestion
• Heartburn
• Rashes
• Itching
• Hair loss
• Skin discolouration
• Chest discomfort
• Muscle pain
• Joint pain
• Swelling over extremities
• Pain or swelling or redness over the injection site
• Weakness
• Confusion
• Headache
• Dizziness
• Extreme weakness
Common Side Effects
• Bruising
• Unusual bleeding
• Facial swelling
• Respiratory distress, breathing difficulty, rapid breathing, tachypnoea
• Sore throat
• High
• grade fever with chills
• Other signs of infection
How To Use
Decintas 30 mg Injection is available in powder form, which must be diluted and administered into the vein (IV) slowly as directed by your doctor. Decintas Injection is administered by a doctor or nurse at a hospital or clinical setting. The dosage, frequency, and interval (duration of infusion) depend upon your medical condition, body size, lab test results, and response towards the treatment given. Don't administer this drug by yourself; it must be administered under medical supervision by health care professionals only. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol, as it may increase your risk of liver damage. Do not self-administer this Decintas 30 mg Vial.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Decintas 30 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Decintas 30 mg Injection is safe for use in patients with mild to moderate kidney disease; no dose adjustment of Decintas 30 mg Vial is recommended. The use of the Decintas 30 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Anti-cancer Drug Decintas. Decintas 30 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Decintas Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Decintas 30 mg Injection is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended; it may worsen the patient's condition.
• Pregnancy: Use of Decintas Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Decintas 30 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Decitabine Injection 30 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Decintas 30 mg.